DDO antibody (C-Term)

Catalog No. ABIN926708

The Rabbit Polyclonal anti-DDO antibody has been validated for WB. It is suitable to detect DDO in samples from Human.

Quick Overview for DDO antibody (C-Term) (ABIN926708)

Target: DDO (D-Aspartate Oxidase (DDO))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This DDO antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-DDO Antibody

Binding Specificity: C-Term

Purification: Purified

Immunogen: DDO antibody was raised in rabbit using the C terminal of DDO as the immunogen

Application Details

Application Notes: Optimal conditions should be determined by the investigator.

Comment:

DDO Blocking Peptide, (ABIN5613150), is also available for use as a blocking control in assays to test for specificity of this DDO antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for DDO

Target: DDO (D-Aspartate Oxidase (DDO))

Alternative Name: DDO

Background: The protein encoded by this gene is a peroxisomal flavoprotein that catalyzes the oxidative deamination of D-aspartate and N-methyl D-aspartate. Flavin adenine dinucleotide or 6-hydroxyflavin adenine dinucleotide can serve as the cofactor in this reaction. Two transcript variants encoding different isoforms have been found for this gene. Synonyms: Polyclonal DDO antibody, Anti-DDO antibody, D-aspartate oxidase antibody, DASOX antibody, DDO-1 antibody, DDO-2 antibody, FLJ45203 antibody.